No Data
No Data
Express News | Senti Biosciences Announces $8M CIRM Grant To Support Clinical Development Of SENTI-202 CAR-NK Cell Therapy For Hematologic Malignancies; First Tranche Expected In August 2024
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Express News | Senti Bio Announces 1-for-10 Reverse Stock Split, Effective Jun. 17
Express News | Senti Biosciences : Board of Directors Has Determined to Effect a One-for-Ten (1-for-10) Reverse Stock Split
Express News | Senti Bio Announces Reverse Stock Split
12 Health Care Stocks Moving In Thursday's Pre-Market Session
No Data